ACUTE MYOCARDITIS IN CHILDREN IN THE BACKGROUND OF COMMUNITY-ACQUIRED PNEUMONIA: CLINICAL FEATURES
Main Article Content
Abstract
Pneumonia in children is one of the pressing problems of pediatrics, which is determined by the continued high incidence and severe prognosis, especially in young children. The purpose of the study was to evaluate the effectiveness of carnitine in the treatment and prevention of myocarditis in children. We examined 46 children aged from 6 months to 7 years with pneumonia, whom we divided into 2 groups. Group I (control) included 23 children who were on standard treatment. Group II (main) included 23 sick children with pneumonia who had disorders of the cardiovascular system, the presence of which was confirmed by instrumental methods. The results obtained emphasize that against the background of community-acquired pneumonia, all symptoms of acute heart failure are masked, the cause of which in most cases is acute coronary insufficiency; changes in the heart muscle with this pathology in children increase the risk of severe undesirable complications from the heart.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Afonaskov O.V. Acute myocarditis in young patients with community-acquired pneumonia/ Dis. . Ph.D. honey. nauk.- Khabarovsk, 2005.- 127 p.
Bakirova V.E. Assessment of variability of respiratory and heart rhythms in patients with community-acquired pneumonia7 Dis. .cand. honey. nauk.-Ufa, 2006.-159 p.
Basargina, E.N. Myocarditis in children: a manual for doctors / E.N. Basargina. - M., 2008. - 27 p.
Bort L.B., Chernik M.B. Factors influencing the course of community-acquired pneumonia // Abstracts of the 13th National Congress on Respiratory Diseases. November 10-14, 2003. St. Petersburg, 2003. - P. 236.
Vishnyakova L.A., Nikitina M.A., Petrova S.I. and others. The role of Streptococcus pneumoniae, Mycoplasma pneumonia and Chlamydia pneumonia in community-acquired pneumonia in children // Pulmonology. - 2008. - No. 3. - P. 43-47.
Grigoriev K.I. Modern view of pneumonia in children and approaches to its treatment and prevention // Medical assistance. - 2005. - No. 2. - P. 3-9.
Clinical recommendations for pediatric cardiology and rheumatology / ed. M.A. Shkolnikova, E.I. Alekseeva. - M., 2011. - 143 p.
Leontyeva I.V. Lectures on pediatric cardiology. Medical practice. 2005.318-322
Ruzhentsova, T.A. Metabolic therapy of myocarditis and cardiomyopathies in children with common acute infectious diseases / T.A. Ruzhentsova, A.V. Gorelov, T.V. Smirnova, L.A. Happy // Infectious diseases. - 2010. - T. 8, No. 3. - P.39-45.
Strelyaeva, A.V. Toxic cardiopathy and myocarditis of pecilomycosis and other etiologies in children / A.V. Strelyaeva, Kh.N. Shadyeva, N.B. Lazareva [and others] // Russian Journal of Cardiology. - 2010. - No. 3. - P.46-52.11. Plouffe JF, File TM Jr, Breiman RF. et al. Reevaluation of the definition Legionnaire’s disease: use of the urinary antigen assay. Community Bas Pneumonia Incidence Study Group. Clin Infect Dis 1995; 20: 1286-91.